NIPER Mohali gets patent for its invention for new anti-TB compound
The Indian Patent Office (IPO) has granted a patent application submitted by the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, for the rights of a compound as anti-tubercular agents and an improved process for its preparation, which is envisaged to overcome the shortcomings of the existing drugs. The patent office has granted patent to the invention - Novel 2-(2'-Aminophenyl) benzazoles as potential anti-tubercular agents and improved process of preparation thereof - for which an application was filed by the NIPER on September 10, 2015. A hearing was held on May 20, 2022, and based on the discussions during the hearing, the institute was asked to amend the claims and submit it within 15 days from the date of hearing.
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
